Research Articles

A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children

We report here the results of a randomized double blind trial comparing coartemether (CGP56697), a combination of artemether and benflumetol, with pyrimethamine/sulfadoxine (P/S). Two hundred eighty-seven children 1-5 years of age with uncomplicated falciparum malaria were enrolled at two centers in The Gambia between July 1996 and December 1996. Following treatment, children were visited at home every 24 hr until a blood film free of asexual parasites was obtained. Genotyping of parasites was used to distinguish recrudescence from new infections. Three days after the start of treatment, 133 (100%) of the CGP56697-treated children compared with 128 (93.4%) of children treated with P/S had cleared their parasites (P = 0.003). The day 15 cure rate was 93.3% for CGP56697 and 97.7% for P/S (P = 0.13). Within the third and fourth week after initiation of therapy, 20 children treated with CGP56697 and one of the P/S-treated children returned with second malaria episodes (P < 0.0001). Genotyping suggested that the majority (19 of 23 [82.6%]) of these second episodes were due to new infections, supporting the World Health Organization recommendation that longer follow-up is not relevant for the assessment of drug efficacy. At the two-week follow-up, 28.9% of the P/S treated children but none of the CGP56697-treated children carried gametocytes (P < 0.0001). This study showed that CGP56697 is safe in African children with acute uncomplicated falciparum malaria, clears parasites more rapidly than P/S, and results in fewer gametocyte carriers. More frequent new infections within the third and fourth week following treatment with CGP56697 than treatment with P/S are likely to be due to the short prophylactic effect of CGP56697.

This article has been cited by other articles:

				I. SAGARA, A. DICKO, A. DJIMDE, O. GUINDO, M. KONE, Y. TOLO, M. A. THERA, M. SOGOBA, M. FOFANA, A. OUATTARA, et al. A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in mali. Am J Trop Med Hyg, October 1, 2006; 75(4): 630 - 636. [Abstract] [Full Text] [PDF]

				K. Chotivanich, J. Sattabongkot, R. Udomsangpetch, S. Looareesuwan, N. P. J. Day, R. E. Coleman, and N. J. White Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother., June 1, 2006; 50(6): 1927 - 1930. [Abstract] [Full Text] [PDF]

				M. MAKANGA, Z. PREMJI, C. FALADE, J. KARBWANG, E. A. MUELLER, K. ANDRIANO, P. HUNT, and P. I. DE PALACIOS EFFICACY AND SAFETY OF THE SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE IN PEDIATRICS WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA Am J Trop Med Hyg, June 1, 2006; 74(6): 991 - 998. [Abstract] [Full Text] [PDF]

				M. G. ALECRIM, M. V. LACERDA, M. P. MOURAO, W. D. ALECRIM, A. PADILHA, B. S. CARDOSO, and M. BOULOS SUCCESSFUL TREATMENT OF PLASMODIUM FALCIPARUM MALARIA WITH A SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE VERSUS QUININE-DOXYCYCLINE IN THE WESTERN AMAZON REGION OF BRAZIL Am J Trop Med Hyg, January 1, 2006; 74(1): 20 - 25. [Abstract] [Full Text] [PDF]

				R. L. Hallett, C. J. Sutherland, N. Alexander, R. Ord, M. Jawara, C. J. Drakeley, M. Pinder, G. Walraven, G. A. T. Targett, and A. Alloueche Combination Therapy Counteracts the Enhanced Transmission of Drug-Resistant Malaria Parasites to Mosquitoes Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3940 - 3943. [Abstract] [Full Text] [PDF]

				A. O. Talisuna, P. Bloland, and U. D'Alessandro History, Dynamics, and Public Health Importance of Malaria Parasite Resistance Clin. Microbiol. Rev., January 1, 2004; 17(1): 235 - 254. [Abstract] [Full Text] [PDF]

				A. CATTAMANCHI, D. KYABAYINZE, A. HUBBARD, P. J. ROSENTHAL, and G. DORSEY DISTINGUISHING RECRUDESCENCE FROM REINFECTION IN A LONGITUDINAL ANTIMALARIAL DRUG EFFICACY STUDY: COMPARISON OF RESULTS BASED ON GENOTYPING OF MSP-1, MSP-2, AND GLURP Am J Trop Med Hyg, February 1, 2003; 68(2): 133 - 139. [Abstract] [Full Text] [PDF]

				B. Pradines, A. Tall, T. Fusai, A. Spiegel, R. Hienne, C. Rogier, J. F. Trape, J. Le Bras, and D. Parzy In Vitro Activities of Benflumetol against 158 Senegalese Isolates of Plasmodium falciparum in Comparison with Those of Standard Antimalarial Drugs Antimicrob. Agents Chemother., February 1, 1999; 43(2): 418 - 420. [Abstract] [Full Text]

				L. K. Basco, J. Bickii, and P. Ringwald In Vitro Activity of Lumefantrine (Benflumetol) against Clinical Isolates of Plasmodium falciparum in Yaounde, Cameroon Antimicrob. Agents Chemother., September 1, 1998; 42(9): 2347 - 2351. [Abstract] [Full Text]